Mirati Therapeutics Announces Departure of Chief Executive Officer David Meek
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St slips as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
Citi Closes Catalyst Watch on Mirati Therapeutics (MRTX) Citi Closes Catalyst Watch
August 8, 2023 4:08 PM EDTCiti Closes Catalyst Watch on Mirati Therapeutics (NASDAQ: MRTX)
"Expiring Upside 90-Day Catalyst Watch"The analyst comments "This Upside Catalyst Watch call, opened on 10-May-2023, has expired effective immediately and should no longer be relied upon."
... More